Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of MEDITOXIN® in individuals with idiopathic overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Meditoxin (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Overactive Bladder | Phase 3 | Status: UNKNOWN